Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 22.9 million
▲ 2% vs 2024
Profit
Growing€ 868,458
▲ 119% vs 2024
Debts
Low€ 8.5 million
▼ 25% vs 2024
Exphar from Nivelles, company number BE0421802718, closed financial year 2025 with a result of € 868,458 after tax. For that financial year Exphar recorded revenue of € 22.9 million and equity of € 5.5 million. Compared with financial year 2024, the result moved from € 396,568 to € 868,458. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
What happened at Exphar?
What happened at Exphar in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- LHVK SRL stepped down as director. NBB
- Ricardo ALVES MARTINS stepped down as director. NBB
- Koen SMESSAERT stepped down as director. NBB
- Jean-Olivier COLLINET stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 868,458 (▲ 119% vs 2024). Source: NBB ↗
- Ricardo ALVES MARTINS became a director. NBB
- Koen SMESSAERT became a director. NBB
- Jean-Olivier COLLINET became a director. NBB
In short
From € 1.6 million profit in 2021 to € 868,458 profit in 2025.
Paid € 1.9 million in corporate taxes since 2021.
Best year ever: 2021, with € 1.6 million profit.
Paid out € 3.5 million in dividends to the owners in total.
A new publication or filing at Exphar? We notify you, reason included.
Follow ExpharNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of EXPHARLAB LIMITED, 100% of H&H Pharma LTD and 5.1% of GRACURE itself.
Directors
According to the 2025 annual accounts
Ricardo ALVES MARTINS
Director
since 2026 · until 2028
Director · represented by Laurent HAVERBEKE
since 2024 · until 2028
Koen SMESSAERT
Director
since 2026 · until 2028
since 2025 · until 2027
Establishments
Establishment units
Physical locations of this company
Avenue Thomas Edison 105
1402 Nivelles
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0421.802.718
- VAT number
- BE 0421.802.718
- Registered office
- Avenue Thomas Edison 105, 1402 Nivelles
- Names & denominations
- Exphar
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 August 1981
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen